TP53 and neoplasm: The sensitivity, specificity and concordance of acfDNA compared with tumor testing for TP53 pathogenic variant detection were 97% (95% IC: 86%-100%), 83% (95% IC: 43%-100%) and 95% (K = 0,81: P < 0,001) respectively.